Other Clinical Trial - Safety & Efficacy of XJ-Procedure in Patients With

Status Not yet recruiting

Clinical Trial Summary

This is a national, multicenter, open-label, randomized, controlled, endpoint-blinded clinical trial of patients diagnosed with ATAAD and undergoing "Sun's procedure" coordinated by the First Affiliated Hospital of Xi'an Jiaotong University, China. Per the protocol, "Sun's procedure" combined with "XJ-Procedure" in the anastomosis of the aortic root and Sun's procedure combined with regular suturing methods of the aortic root will be compared.

Clinical Trial Description

In this study, the investigators will prospectively enroll patients diagnosed with ATAAD and undergo "Sun's procedure" from November 2024 to November 2027 in several centers, including the First Affiliated Hospital of Xi'an Jiaotong University, and will randomly divide them into XJ-procedure group and control group. "The patients in the XJ-procedure group will undergo "Sun's procedure", in which the anastomosis of the aortic root will be performed with the XJ-procedure. The patients in the control group will also undergo "Sun's procedure", in which the anastomosis of the aortic root will be performed with each center. The primary outcome event is all-cause mortality within 12 months after surgery. Secondary outcome events are (1) incidence of residual aortic root entrapment (during hospitalization, follow-up 3 months, 6 months, 12 months) (2) rate of secondary surgery for hemostasis due to root hemorrhage (during hospitalization) (3) incidence of anastomotic pseudoaneurysm (during hospitalization, follow-up 3 months, 6 months, 12 months) (4) rate of severe regurgitation of residual aortic valves (during hospitalization, follow-up 3 months, 6 months, 12 months) (5) Incidence of major adverse cardiovascular and cerebrovascular events (MACCE) (during hospitalization, follow-up 3 months, 6 months, 12 months). ;

Study Design

Related Conditions & MeSH terms

Aortic Diseases
Aortic Dissection
Complication of Surgical Procedure
Type A Aortic Dissection

Clinical Trial Details

NCT number	NCT06199401
Study type	Interventional
Source	First Affiliated Hospital Xi'an Jiaotong University
Contact	Yang Yan
Phone	+86.29.85323869
Email	yangyan3@xjtu.edu.cn
Status	Not yet recruiting
Phase	N/A
Start date	October 1, 2024
Completion date	December 1, 2027

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02789579` - The Preventive Infection Role of One Week Antibiotics Before Minimally Invasive Upper Tract Lithotomy	Early Phase 1
Withdrawn	`NCT02374294` - TCOT Effectiveness in Preventing Wound Infections in Perineal Resections	Phase 2
Completed	`NCT02252562` - Hand Hygiene and Hospital Acquired Infections	N/A
Completed	`NCT01757704` - Factors Responsible for the Effectiveness of the Lund De-airing Technique	N/A
Recruiting	`NCT05005117` - Laparoscopic Approach for Emergency Colon Resection	N/A
Enrolling by invitation	`NCT03234543` - Remote Ischemic Conditioning in Abdominal Surgery	N/A
Completed	`NCT04849702` - Comparison of the Clavien-Dindo and Comprehensive Complication Index
Completed	`NCT04120324` - Incidence of 30 Day Return to Hospital Following Same Day Discharge Total Hip Arthroplasty
Recruiting	`NCT05761821` - Key Factors of Leadless Pacemaker Implantation With Implantation Site, Complications and Prognosis
Active, not recruiting	`NCT05795127` - Risk for Reoperation After First MTP Joint Arthrodesis
Completed	`NCT04550156` - Evaluation of the Introduction of a Colorectal Bundle in Left Sided Colorectal Resections	N/A
Recruiting	`NCT05194943` - Trends and Safety in Revisional Bariatric Surgery in Italy
Not yet recruiting	`NCT03313986` - Outcomes of Surgical Correction of Penile Curvature in Adult	N/A
Enrolling by invitation	`NCT04456530` - Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study	Phase 2/Phase 3
Completed	`NCT03125798` - Comparison of LigaSure to Conventional Electrocoagulation in Video-assisted Thoracoscopic Surgery Lobectomy	N/A
Completed	`NCT04226482` - Review of Efficacy of Used ultraSonic Energy Device	N/A
Completed	`NCT01739374` - Efficacy and Safety of Reduced Pelvic Floor Mesh Implants	Phase 2/Phase 3
Completed	`NCT01346709` - Prospective Evaluation of a RIsk Score for Postoperative Pulmonary COmPlications in Europe
Recruiting	`NCT02212054` - A Trial on Treatments of Hirschsprung Allied Disease	N/A
Recruiting	`NCT06351865` - Feasibility Study to Evaluate the Use of Patient Reported Complications After Digital Consent

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Safety and Efficacy of XJ-Procedure in Patients With Acute Type A Aortic Dissection Surgery — ADVANCED-XJ-?

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms